Impact of Treatment Induced Premature Menopause on Quality of Life

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00185718
First received: September 12, 2005
Last updated: December 12, 2012
Last verified: December 2012
  Purpose

To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.


Condition
Menopause, Premature

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    To describe the impact of premature menopause on sexuality and quality of life.

  • Sexuality [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    To describe the impact of premature menopause on sexuality and quality of life.


Enrollment: 97
Study Start Date: November 2003
Study Completion Date: September 2010
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women become menopausal as a result of BMT

Criteria

Inclusion Criteria:

  • premenopausal
  • sexually active women
  • able to read and write English

Exclusion Criteria:

- postmenopausal females

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00185718

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Karl G. Blume Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00185718     History of Changes
Other Study ID Numbers: BMT160, 79700, BMT160, 13644
Study First Received: September 12, 2005
Last Updated: December 12, 2012
Health Authority: United States: Food and Drug Administration
United States: Institutional Review Board

Additional relevant MeSH terms:
Menopause, Premature
Primary Ovarian Insufficiency
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases

ClinicalTrials.gov processed this record on August 20, 2014